Home
Iol Chemicals & Pharmaceuticals Ltd EPS

IOL Chemicals & Pharmaceuticals Ltd
NSE: IOLCP
EPS
Key Highlights
- The Earning per Share of IOL Chemicals & Pharmaceuticals Ltd is ₹ 16.57 as of 21 Feb 25 .
- The earning per share of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 7.81 to ₹ 3.5 over 7 quarters. This represents a CAGR of -36.79% .
Historical Earning per Share of IOL Chemicals & Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of IOL Chemicals & Pharmaceuticals Ltd
Company Fundamentals for IOL Chemicals & Pharmaceuticals Ltd
Market Cap
2,004 Cr
EPS
16.6
P/E Ratio (TTM)
20.6
P/B Ratio (TTM)
1.2
Day’s High
348.9
Day’s Low
339.0
DTE
0.1
ROE
6.0
52 Week High
537.05
52 Week Low
327.65
ROCE
8.3
Market Price of IOL Chemicals & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 341.4 |
20 Feb 2025 | 341.45 |
19 Feb 2025 | 333 |
18 Feb 2025 | 332.1 |
17 Feb 2025 | 340.9 |
14 Feb 2025 | 337.4 |
13 Feb 2025 | 351.7 |
12 Feb 2025 | 357.35 |
11 Feb 2025 | 367.85 |
10 Feb 2025 | 379.4 |
SWOT Analysis Of IOL Chemicals & Pharmaceuticals Ltd
BlinkX Score for IOL Chemicals & Pharmaceuticals Ltd
Asset Value vs Market Value of IOL Chemicals & Pharmaceuticals Ltd
Market Value
₹ 2,004
Asset Value
Value addition
0.8 X
₹ 1,121
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
IOL Chemicals & Pharmaceuticals Ltd | 2004 | 16.57 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
IOL Chemicals & Pharmaceuticals Ltd | 2004 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of IOL Chemicals & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of IOL Chemicals & Pharmaceuticals Ltd
Historical Revenue of IOL Chemicals & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of IOL Chemicals & Pharmaceuticals Ltd
Historical EBITDA of IOL Chemicals & Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of IOL Chemicals & Pharmaceuticals Ltd
Historical Net Profit of IOL Chemicals & Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of IOL Chemicals & Pharmaceuticals Ltd
Dividend Payout Over Time
IOL Chemicals & Pharmaceuticals Ltd News Hub
IOL Chemicals & Pharmaceuticals Ltd leads gainers in 'A' group
Allcargo Logistics Ltd, Angel One Ltd, GHCL Ltd and KEI Industries Ltd are among the other gainers i
Read more
20 Aug 24
IOL Chemicals & Pharmaceuticals to hold board meeting
IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 D
Read more
19 Dec 24
IOL Chemicals & Pharmaceuticals consolidated net profit declines 34.65% in the June 2024 quarter
Net profit of IOL Chemicals & Pharmaceuticals declined 34.65% to Rs 29.97 crore in the quarter ended
Read more
10 Aug 24
IOL Chemicals jumps after board to mull stock split proposal
The company will consider and approve the alteration in the share capital of the company by sub-divi
Read more
19 Dec 24